Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)

Clinical trial NCT02445131 · COMPLETED

Trial details

NCT number: NCT02445131
Sponsor: German CLL Study Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leucemia

Start date: 2015-05-28
Primary completion: 2022-03-09
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.